Next, to evaluate the status of canonical TGF-β signaling in PAH and non-diseased PAVSMC, we tested C-terminal phosphorylation rates of Smad2 and Smad3, molecular markers of Smad activation [9]. Here, TGFB1 is linked to pulmonary arterial hypertension.